Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Blind, Parallel Group Trial of Novel, On-Demand Virtual Reality to Amplify Practice Efficacy (NO VAPE) Added to Cognitive Behavioral Therapy for Nicotine Vaping Cessation

NCT07223879 is registered in ClinicalTrials.gov with Charles River Analytics as lead sponsor.

NCT NCT07223879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07223879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Blind, Parallel Group Trial of Novel, On-Demand Virtual Reality to Amplify Practice Efficacy (NO VAPE) Added to Cognitive Behavioral Therapy for Nicotine Vaping Cessation
Lead sponsor
Charles River Analytics
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2025
Completion date
February 29, 2028
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

no vape + 12 weeks of standard cbt, sham no vape + 12 weeks standard cbt